Thomas Merdan
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 16
- Advanced biosensing and bioanalysis techniques 10
- Genetics 8
- Virus-based gene therapy research 8
- Co-authors
- Thomas Kissel (14 shared papers)Jindřich Kopeček (4 shared papers)Klaus Kunath (5 shared papers)Xintao Shuai (3 shared papers)Holger Petersen (4 shared papers)Udo Bakowsky (4 shared papers)Florian T. Unger (3 shared papers)Dagmar Fischer (3 shared papers)
- Journals
- Bioconjugate Chemistry (7 papers)Journal of Controlled Release (2 papers)Macromolecules (1 paper)Drug Delivery and Translational Research (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)
- Partner nations
- GermanyUnited StatesCzechia
In The Last Decade
Thomas Merdan
23 papers receiving 2.5k citations
Thomas Merdan's Hit Papers
Peers
Comparison fields: 5 of 103
- Biomaterials 726
- Pharmaceutical Science 173
- Molecular Biology 1.8k
- Genetics 622
- Polymers and Plastics 262
Countries citing papers authored by Thomas Merdan
This map shows the geographic impact of Thomas Merdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Merdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Merdan more than expected).
Fields of papers citing papers by Thomas Merdan
This network shows the impact of papers produced by Thomas Merdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Merdan. The network helps show where Thomas Merdan may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Merdan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prospects for cationic polymers in gene and oligonucleotide therapy against cancer Hit paper breakdown → | 2002 | 644 |
| 2 | 2004 | 283 | |
| 3 | 2005 | 216 | |
| 4 | 2003 | 188 | |
| 5 | 2003 | 152 | |
| 6 | 2002 | 126 | |
| 7 | 2003 | 113 | |
| 8 | 2002 | 107 | |
| 9 | 2007 | 101 | |
| 10 | 2005 | 90 | |
| 11 | 2002 | 77 | |
| 12 | 2009 | 65 | |
| 13 | 2022 | 58 | |
| 14 | 2006 | 54 | |
| 15 | 2008 | 51 | |
| 16 | 2004 | 49 | |
| 17 | 2007 | 39 | |
| 18 | 2004 | 36 | |
| 19 | 2009 | 36 | |
| 20 | 2023 | 18 |
About Thomas Merdan
Thomas Merdan is a scholar working on Molecular Biology, Genetics, Biomaterials, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 23 papers that have together received 2.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (16 papers), Advanced biosensing and bioanalysis techniques (10 papers), Virus-based gene therapy research (8 papers), Nanoparticle-Based Drug Delivery (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cell Adhesion Molecules Research (2 papers), HER2/EGFR in Cancer Research (2 papers) and Advanced Drug Delivery Systems (2 papers). The work is most often cited by research in Biomaterials (726 citations), Pharmaceutical Science (173 citations), Molecular Biology (1.8k citations), Genetics (622 citations) and Polymers and Plastics (262 citations). Thomas Merdan has collaborated with scholars based in Germany, United States and Czechia. Frequent co-authors include Thomas Kissel, Jindřich Kopeček, Klaus Kunath, Xintao Shuai, Holger Petersen, Udo Bakowsky, Florian T. Unger, Dagmar Fischer, Andreas Schaper and Fu Xi. Their work appears in journals such as Bioconjugate Chemistry, Journal of Controlled Release, Macromolecules, Drug Delivery and Translational Research and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.